Boston scientific corporation (BSX)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07
Net sales

10,735

9,823

9,048

8,386

7,477

7,380

7,143

7,249

7,622

7,806

8,188

8,050

8,357

Cost of products sold

3,116

2,813

2,593

2,424

2,173

2,210

2,174

2,349

2,659

2,599

2,576

2,469

2,342

Gross profit

7,620

7,011

6,455

5,962

5,304

5,170

4,969

4,900

4,963

5,207

5,612

5,581

6,015

Operating expenses:
Selling, general and administrative expenses

3,941

3,569

3,294

3,099

2,873

2,902

2,674

2,535

2,487

2,580

2,635

2,589

2,909

Research and development expenses

1,174

1,113

997

920

876

817

861

886

895

939

1,035

1,006

1,091

Royalty expense

65

70

68

79

70

111

140

153

172

185

191

203

202

Loss on program termination

-

-

-

-

-

-

-

-

-

-

16

-

-

Amortization expense

699

599

565

545

495

438

410

395

421

513

511

543

620

Goodwill impairment charges

-

-

-

-

-

-

423

4,350

697

1,817

0

2,613

-

Intangible asset impairment charges

105

35

4

11

19

195

53

142

21

65

12

177

21

Contingent consideration expense (benefit)

-35

-21

-80

29

123

-85

4

-6

7

2

0

-

-

Purchased research and development

-

-

-

-

-

-

-

-

-

-

21

43

85

Acquisition-related milestone

-

-

-

-

-

-

-

-

-

250

0

250

-

Loss on assets held for sale

-

-

-

-

-

-

-

-

-

-

-

-

560

Restructuring charges (credits)

38

36

37

28

26

69

101

136

89

116

63

78

176

Litigation-related net charges (credits)

115

103

285

804

1,105

1,036

221

192

48

-104

2,022

334

365

Gain on divestiture

-

-

-

-

-

12

38

15

778

0

0

250

-

Operating expenses

6,102

5,504

5,170

5,515

5,587

5,471

4,849

8,768

4,059

5,863

6,506

7,086

6,029

Operating income (loss)

1,518

1,506

1,285

447

-283

-301

120

-3,868

904

-656

-894

-1,505

-14

Other income (expense):
Interest expense

473

241

229

233

284

216

324

261

281

393

407

468

570

Other, net

-358

156

-124

-37

-83

8

-19

22

19

-14

-7

-58

15

Income (loss) before income taxes

687

1,422

933

177

-650

-509

-223

-4,107

642

-1,063

-1,308

-2,031

-569

Income tax expense (benefit)

-4,013

-249

828

-170

-411

-390

-102

-39

201

2

-283

5

-74

Net income (loss)

4,700

1,671

104

347

-239

-119

-121

-4,068

441

-1,065

-1,025

-2,036

-495

Net income (loss) per common share — basic

3.38

1.21

0.08

0.26

-0.18

-0.09

-0.09

-2.89

0.29

-0.70

-0.68

-1.36

-0.33

Net income (loss) per common share — assuming dilution

3.33

1.19

0.08

0.25

-0.18

-0.09

-0.09

-2.89

0.29

-0.70

-0.68

-1.36

-0.33

Pension termination charges

-

-

-

-

44

0

0

-

-

-

-

-

-

Weighted-average shares outstanding
Basic

1,391

1,381

1,370

1,357

1,341

1,324

1,341

1,406

1,509

1,517

1,507

1,498

1,486

Assuming dilution

1,410

1,401

1,392

1,377

1,341

1,324

1,341

1,406

1,519

1,517

1,507

1,498

1,486